Oteseconazole
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance.
Journal: Journal of fungi (Basel, Switzerland)
Published: February 20, 2026
Advances in vulvovaginal candidiasis research: a comprehensive review from epidemiology, diagnosis, treatment to resistance mechanisms.
Journal: Frontiers in microbiology
Published: February 14, 2026
Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial.
Journal: Drug design, development and therapy
Published: January 27, 2026
Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents.
Journal: Journal of fungi (Basel, Switzerland)
Published: January 14, 2026
New antifungals for the treatment of invasive mould disease.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 05, 2025
Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis.
Journal: Journal of women's health (2002)
Published: November 08, 2025
In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae.
Journal: Microbiology spectrum
Published: June 23, 2025
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.
Journal: Expert review of anti-infective therapy
Published: June 04, 2025
Design, Synthesis, and Biological Activity Evaluation of Deuterated Diphenyl Azole Alcohol-Based CYP51 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Last Updated: 06/30/2026